News
CARL
11.56
+11.32%
1.18
Carlsmed Price Target Announced at $17.00/Share by Needham
Dow Jones · 8h ago
Needham Initiates Coverage On Carlsmed with Buy Rating, Announces Price Target of $17
Benzinga · 9h ago
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL) and Zimmer Biomet Holdings (ZBH)
TipRanks · 10h ago
Carlsmed initiated with a Buy at Needham
TipRanks · 11h ago
Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL)
TipRanks · 11h ago
CARLSMED INC <CARL.O>: NEEDHAM INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $17
Reuters · 11h ago
U.S. RESEARCH ROUNDUP- Dow, Palo Alto Networks, Zions Bancorporation
Reuters · 12h ago
Weekly Report: what happened at CARL last week (0622-0626)?
Weekly Report · 2d ago
Carlsmed, Inc. (CARL) Gets a Buy from BTIG
TipRanks · 06/23 21:40
Weekly Report: what happened at CARL last week (0615-0619)?
Weekly Report · 06/22 09:07
Weekly Report: what happened at CARL last week (0608-0612)?
Weekly Report · 06/15 09:07
Weekly Report: what happened at CARL last week (0601-0605)?
Weekly Report · 06/08 09:07
Carlsmed Shareholders Back Directors and Auditor at Meeting
TipRanks · 06/03 21:08
Carlsmed holds annual shareholder meeting, elects two directors
PUBT · 06/03 20:09
Piper Sandler Keeps Their Buy Rating on Carlsmed, Inc. (CARL)
TipRanks · 06/03 11:28
Weekly Report: what happened at CARL last week (0525-0529)?
Weekly Report · 06/01 09:07
Carlsberg Research Laboratory unlocks the genetic code of hops, helping protect the future of beer in a warming world
Barchart · 05/27 04:00
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
NASDAQ · 05/25 13:55
Weekly Report: what happened at CARL last week (0518-0522)?
Weekly Report · 05/25 09:08
Weekly Report: what happened at CARL last week (0511-0515)?
Weekly Report · 05/18 09:08
More
Webull provides a variety of real-time CARL stock news. You can receive the latest news about CARLSMED INC through multiple platforms. This information may help you make smarter investment decisions.
About CARL
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights for each surgeon. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.